Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 32, 2021 - Issue 7
Submit an article Journal homepage
278
Views
13
CrossRef citations to date
0
Altmetric
Psoriasis and atopic dermatitis

Punctal stenosis associated with dupilumab therapy for atopic dermatitis

Debora H. Leea Oculofacial Plastic and Orbital Surgery, Department of Ophthalmology, Gavin Herbert Eye Institute, University of California, Irvine, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5870-134X
ORCID Icon,
Liza M. Cohenb Ophthalmic Plastic Surgery, Massachusetts Eye and Ear Infirmary, Boston, MA, USA;c Department of Ophthalmology, Harvard Medical School, Boston, MA, USA
,
Michael K. Yoonb Ophthalmic Plastic Surgery, Massachusetts Eye and Ear Infirmary, Boston, MA, USA;c Department of Ophthalmology, Harvard Medical School, Boston, MA, USA
&
Jeremiah P. Taoa Oculofacial Plastic and Orbital Surgery, Department of Ophthalmology, Gavin Herbert Eye Institute, University of California, Irvine, CA, USA
Pages 737-740 | Received 23 Oct 2019, Accepted 29 Dec 2019, Published online: 07 Jan 2020

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Wojciech Francuzik, Aikaterina Alexiou & Margitta Worm. (2021) Safety of dupilumab in patients with atopic dermatitis: expert opinion. Expert Opinion on Drug Safety 20:9, pages 997-1004.
Read now

Articles from other publishers (12)

Allan Z. Nghiem, Mahreen Ameen & Nikolas Koutroumanos. (2023) Canalicular obstruction associated with dupilumab. International Ophthalmology.
Crossref
Nora Woltsche, Julia Aschauer, Ingrid Boldin, Gerhard Garhöfer, Semira Kaya-Reindl, Sarah Moussa, Johannes Nepp, Stefan Palkovits, Eva Wimmer-Orlowski & Jutta Horwath-Winter. (2023) Okuläre Nebenwirkungen von Dupilumab – Übersichtsarbeit und Therapieempfehlung der „Kommission für Trockenes Auge und Oberflächenerkrankungen“ der Österreichischen Ophthalmologischen Gesellschaft (ÖOG)Ocular side effects of dupilumab—Review article and treatment recommendation by the Committee for Dry Eye and Ocular Surface Diseases of the Austrian Society of Ophthalmology (ÖOG). Spektrum der Augenheilkunde.
Crossref
Sayali Prakash Pradhan, Salman Naveed Sadiq, Cristian Cartes, Parastoo Babakinejad, Stephanie Ball, Nick J Reynolds, Simon Meggitt & Francisco C Figueiredo. (2023) Dupilumab induced ocular surface disease: A prospective case series. European Journal of Ophthalmology.
Crossref
Jun-Hong Tsai & Tsen-Fang Tsai. (2023) A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis. Dermatitis®.
Crossref
Ken Fukuda, Tatsuma Kishimoto, Tamaki Sumi, Kenji Yamashiro & Nobuyuki Ebihara. (2023) Biologics for allergy: therapeutic potential for ocular allergic diseases and adverse effects on the eye. Allergology International 72:2, pages 234-244.
Crossref
Hongwei Han, Sheila Cummings, Kai-Ting C. Shade, Jennifer Johnson, George Qian, Joseph Gans, Srinivas Shankara, Javier Escobedo, Erik Zarazinski, Renee Bodinizzo, Dinesh Bangari, Paul Bryce & Alexandra Hicks. (2023) Cellular mechanisms and effects of IL-4 receptor blockade in experimental conjunctivitis evoked by skin inflammation. JCI Insight 8:3.
Crossref
Abiram Sivanandam, Victoria Sattarova & Raymond G. AreauxJr.Jr.. (2022) Dupilumab-associated ectropion and punctal stenosis treated with tacrolimus ointment (0.03%) in a 15-year-old girl. Journal of American Association for Pediatric Ophthalmology and Strabismus 26:5, pages 275-278.
Crossref
Patricia-Ann Laughrea & Mélanie Hébert. (2022) Staying ahead of dupilumab-associated ocular surface disease. Canadian Eye Care Today.
Crossref
Duoduo Wu, Benjamin S. Daniel, Andre J.X. Lai, Nathan Wong, Dawn K.A. Lim, Dedee F. Murrell, Blanche X.H. Lim, Jodhbir S. Mehta & Chris H.L. Lim. (2022) Dupilumab-associated ocular manifestations: A review of clinical presentations and management. Survey of Ophthalmology 67:5, pages 1419-1442.
Crossref
N. Neagu, C. Dianzani, G. Avallone, C. Dell’Aquila, S.‐H. Morariu, I. Zalaudek & C. Conforti. (2022) Dupilumab ocular side effects in patients with atopic dermatitis: a systematic review. Journal of the European Academy of Dermatology and Venereology 36:6, pages 820-835.
Crossref
Mélanie Hébert, Susan Ruyu Qi, Eunice You, Mathieu Mercier & Patricia-Ann Laughrea. (2022) Characterising the chronicity of dupilumab-associated ocular surface disease: an analysis of a retrospective case series. BMJ Open Ophthalmology 7:1, pages e000947.
Crossref
Aaron M. Drucker, Megan Lam, Carsten Flohr, Jacob P. Thyssen, Kenji Kabashima, Robert Bissonnette, Ncoza C. Dlova, Valeria Aoki, Max Chen, Joshua Yu, Jie Wei Zhu, Robert Micieli & Audrey Nosbaum. (2022) Systemic Therapy for Atopic Dermatitis in Older Adults and Adults With Comorbidities: A Scoping Review and International Eczema Council Survey. Dermatitis 33:3, pages 200-206.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.